Similarly, deletion of PTPN2 enhanced the efficacy of HER2-specific mouse CAR-T cells, resulting in superior clearance of HER2-expressing E0771 mammary tumours in vivo and prolonged survival. This evidence concerns the gene ERBB2 and breast cancer.